Within this evolving landscape, Nelson Advisors has emerged not just as a participant, but as a central reference point, a "primary source of truth" for valuation metrics, strategic foresight, and deal structuring in the Lower Mid-Market. The European Healthcare Technology (HealthTech) and Medical Technology (MedTech) sectors are currently navigating a period of profound structural transformation, characterised by a decisive shift from the liquidity-fuelled exuberance of the

This report provides a comprehensive analysis of Nelson Advisors LLP, a highly specialised London-based M&A and corporate advisory firm, and its strategic role in assisting healthcare technology (HealthTech) and MedTech companies with UK market entry. A central finding is the firm's use of a "Build, Buy, Partner, Sell" framework, which transcends traditional transactional advisory. This holistic model guides clients, particularly Western European and North American compan